Braun Stacey Associates’s Amgen AMGN Stock Holding History

Braun Stacey Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.58M	Sell	4,500 -300	-6%	-$107K	0.05%	93
2025 Q4	$1.57M	Buy	4,800 +300	+7%	+$95.2K	0.05%	93
2025 Q3	$1.27M	Sell	4,500 -34,949	-89%	-$10.1M	0.04%	95
2025 Q2	$11M	Sell	39,449 -2,304	-6%	-$653K	0.4%	85
2025 Q1	$13M	Sell	41,753 -141	-0.3%	-$41.6K	0.53%	72
2024 Q4	$10.9M	Sell	41,894 -12,283	-23%	-$3.64M	0.41%	82
2024 Q3	$17.5M	Buy	54,177 +1,561	+3%	+$511K	0.66%	66
2024 Q2	$16.4M	Sell	52,616 -2,069	-4%	-$608K	0.64%	70
2024 Q1	$15.5M	Buy	54,685 +9,220	+20%	+$2.7M	0.62%	75
2023 Q4	$13.1M	Buy	+45,465	New	+$12.4M	0.59%	74
2022 Q4	–	Sell	-2,700	Closed	-$609K	–	117
2022 Q3	$609K	Sell	2,700 -200	-7%	-$48.5K	0.04%	111
2022 Q2	$706K	Buy	+2,900	New	+$711K	0.04%	114
2019 Q2	–	Sell	-10,664	Closed	-$2.03M	–	116
2019 Q1	$2.03M	Buy	10,664 +901	+9%	+$172K	0.13%	104
2018 Q4	$1.9M	Buy	+9,763	New	+$1.9M	0.15%	104

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Braun Stacey Associates's AMGN Position: Q1 2026 in Review

Braun Stacey Associates reduced its Amgen (AMGN) stake by 6.3% in Q1 2026, selling an estimated $107K and leaving 4,500 shares worth $1.58M. The position accounts for 0.05% of the portfolio, ranked #93.

Braun Stacey Associates first reported a position in AMGN in Q4 2018 and has held it in 14 quarters since. The position peaked at $17.5M in Q3 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Braun Stacey Associates held 4,500 shares of Amgen worth $1.58M as of Q1 2026.
Braun Stacey Associates sold 300 Amgen shares in Q1 2026, an estimated $107K.
Amgen made up 0.05% of Braun Stacey Associates's portfolio in Q1 2026, its #93 holding.
Braun Stacey Associates first reported a position in Amgen in Q4 2018 and has held it in 14 quarters since.
Braun Stacey Associates's Amgen position peaked at $17.5M in Q3 2024.
3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Braun Stacey Associates's 13F filing for Q1 2026, filed 22 Apr 2026.